You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 20, 2024

~ Buy the GENOSYL (nitric oxide) Drug Profile, 2024 PDF Report in the Report Store ~

GENOSYL Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Genosyl patents expire, and what generic alternatives are available?

Genosyl is a drug marketed by Vero Biotech Inc and is included in one NDA. There are twenty-four patents protecting this drug.

This drug has fifty-nine patent family members in five countries.

The generic ingredient in GENOSYL is nitric oxide. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the nitric oxide profile page.

DrugPatentWatch^® Generic Entry Outlook for Genosyl

Indicators of Generic Entry

< Available with Subscription >

Try a Trial

Summary for GENOSYL

International Patents:	59
US Patents:	24
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	17
Clinical Trials:	2
Formulation / Manufacturing:	see details
What excipients (inactive ingredients) are in GENOSYL?	GENOSYL excipients list
DailyMed Link:	GENOSYL at DailyMed

Drug patent expirations by year for GENOSYL

Recent Clinical Trials for GENOSYL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Geno LLC	Phase 3
Geno LLC	Phase 2

See all GENOSYL clinical trials

Pharmacology for GENOSYL

Drug Class	Vasodilator
Physiological Effect	Vasodilation

Anatomical Therapeutic Chemical (ATC) Classes for GENOSYL

R07AX	Other respiratory system products
R07A	OTHER RESPIRATORY SYSTEM PRODUCTS
R07	OTHER RESPIRATORY SYSTEM PRODUCTS
R	Respiratory system

US Patents and Regulatory Information for GENOSYL

GENOSYL is protected by twenty-four US patents.

Patents protecting GENOSYL

Conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT

Nitrogen dioxide storage cassette
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

Nitrogen dioxide storage device
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

Conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT

Systems and devices for generating nitric oxide
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

Nitric oxide therapies
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

Conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

Conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT

Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT

Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT

Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

Conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

Kit for the conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT

Conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT

Conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT

Systems and devices for generating nitric oxide
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

Conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT

Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

Systems and devices for generating nitric oxide
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

Systems and devices for generating nitric oxide
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD FOR DELIVERING NITRIC OXIDE TO A PATIENT WITH PULMONARY HYPERTENSION OR HYPOXIA

Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

Conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Vero Biotech Inc	GENOSYL	nitric oxide	GAS;INHALATION	202860-001	Dec 20, 2019		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Vero Biotech Inc	GENOSYL	nitric oxide	GAS;INHALATION	202860-001	Dec 20, 2019		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
Vero Biotech Inc	GENOSYL	nitric oxide	GAS;INHALATION	202860-001	Dec 20, 2019		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
Vero Biotech Inc	GENOSYL	nitric oxide	GAS;INHALATION	202860-001	Dec 20, 2019		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Vero Biotech Inc	GENOSYL	nitric oxide	GAS;INHALATION	202860-001	Dec 20, 2019		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Vero Biotech Inc	GENOSYL	nitric oxide	GAS;INHALATION	202860-001	Dec 20, 2019		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for GENOSYL

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Vero Biotech Inc	GENOSYL	nitric oxide	GAS;INHALATION	202860-001	Dec 20, 2019	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

EU/EMA Drug Approvals for GENOSYL

Subscribe to access the full database, or Try a Trial
Company	Drugname	Inn	Product Number / Indication	Status	Generic	Biosimilar	Orphan	Marketing Authorisation	Marketing Refusal
Linde Healthcare AB	INOmax	nitric oxide	EMEA/H/C/000337 INOmax, in conjunction with ventilatory support and other appropriate active substances, is indicated:for the treatment of newborn infants ≥34 weeks gestation with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension, in order to improve oxygenation and to reduce the need for extracorporeal membrane oxygenation;as part of the treatment of peri- and post-operative pulmonary hypertension in adults and newborn infants, infants and toddlers, children and adolescents, ages 0-17 years in conjunction to heart surgery, in order to selectively decrease pulmonary arterial pressure and improve right ventricular function and oxygenation.	Authorised	no	no	no	2001-08-01
>Company	>Drugname	>Inn	>Product Number / Indication	>Status	>Generic	>Biosimilar	>Orphan	>Marketing Authorisation	>Marketing Refusal

International Patents for GENOSYL

See the table below for patents covering GENOSYL around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Australia	2010263098	Nitric oxide therapies	⤷ Try a Trial
Japan	2010522130		⤷ Try a Trial
Japan	2011510712		⤷ Try a Trial
Australia	2009282986	Systems and devices for generating nitric oxide	⤷ Try a Trial
Japan	2012179365	CONVERSION OF NITROGEN DIOXIDE (NO2) TO NITRIC OXIDE (NO)	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2008118360		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for GENOSYL

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0786264	SPC/GB08/019	United Kingdom	⤷ Try a Trial	PRODUCT NAME: NITRIC OXIDE (NO); REGISTERED: UK EU/1/01/194/001 20010801
0560928	2002C/003	Belgium	⤷ Try a Trial	PRODUCT NAME: NITRIC OXIDE; REGISTRATION NO/DATE: EU/1/01/194/001 20010801
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.